Revenue: The sum of all revenue fields included for a company's operating activities.
Eton Pharmaceuticals, Inc. (ETON) had Revenue of $22.46M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$22.46M |
$-1.93M |
|
$14.60M |
|
$7.86M |
|
$23.82M |
|
$-1.36M |
|
$-0.59M |
|
$-1.96M |
|
$-1.96M |
|
$-1.93M |
|
$-1.93M |
|
$-1.93M |
|
$-1.93M |
|
$-1.36M |
|
$-0.17M |
|
26.89M |
|
26.89M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$72.00M |
|
$0.29M |
|
$32.51M |
|
$104.51M |
|
$44.18M |
|
$27.59M |
|
$37.20M |
|
$81.38M |
|
$23.13M |
|
$-8.75M |
|
$23.13M |
|
26.82M |
|
| Cash Flow Statement Financials | |
$22.07M |
|
$-0.28M |
|
$0.39M |
|
$14.94M |
|
$37.12M |
|
$22.18M |
|
$4.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.63 |
|
-- |
|
-- |
|
0.54 |
|
1.31 |
|
34.97% |
|
-6.07% |
|
-6.07% |
|
-- |
|
-8.70% |
|
-8.58% |
|
$21.79M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.87 |
|
1.72 |
|
52.42 |
|
-8.33% |
|
22.02% |
|
-1.84% |
|
-3.80% |
|
$0.86 |
|
$0.81 |
|
$0.82 |
|